Journals On Contact Dermatitis
Contact dermatitis usually improves or clears up completely if the substance causing the matter is identified and avoided. Treatments also are available to assist ease the symptoms.Contact dermatitis causes the skin to become itchy, blistered, and dry and cracked. Lighter skin can become red, and darker skin can become dark brown, purple or grey. This reaction usually occurs within a couple of hours or days of exposure to an irritant or allergen. Symptoms can affect any part of the body but most commonly the hands and face.
The best thanks to prevent dermatitis are to avoid contact with the allergens or irritants that cause your symptoms.
If you cannot avoid contact, you can take steps to reduce the risk of the allergens or irritants causing symptoms, including:
Cleaning your skin – if you come into contact with an allergen or irritant, rinse the affected skin with warm water and an emollient as soon as possible.
Using gloves to protect your hands – but take them off every now and again, as sweating can make any symptoms worse; you may find it useful to wear cotton gloves underneath rubber gloves if the rubber also irritates you.
High Impact List of Articles
-
Global Nursing 2020, Switzerland
Rabie'e Al Rashdi
Editorial: Clinical Practice
-
Global Nursing 2020, Switzerland
Rabie'e Al Rashdi
Editorial: Clinical Practice
-
Approach to multiple sclerosis associated uveitis: 3 case reports
Saeed Shahbeigi*, Soheila Kianpour Rad ,Hosein Pakdaman ,Mohammad Hafez Noroozizadeh, SurenaNazarbaghi, Sana Karamolahi, and AyseAltintas
Case Report: Clinical Practice
-
Approach to multiple sclerosis associated uveitis: 3 case reports
Saeed Shahbeigi*, Soheila Kianpour Rad ,Hosein Pakdaman ,Mohammad Hafez Noroozizadeh, SurenaNazarbaghi, Sana Karamolahi, and AyseAltintas
Case Report: Clinical Practice
-
Reintroduction of stimulant treatment for patients with ADHD, after stimulant-related psychosis
M Chammas, GA Ahronheim & L Hechtman
Case Series: Clinical Practice
-
Reintroduction of stimulant treatment for patients with ADHD, after stimulant-related psychosis
M Chammas, GA Ahronheim & L Hechtman
Case Series: Clinical Practice
-
Glossary: Volume 6 Issue 2
Appendices: Clinical Practice
-
Glossary: Volume 6 Issue 2
Appendices: Clinical Practice
-
Continuing evolution of the role of β-blockers in the treatment of hypertension
Thomas D Giles
Review Article: Clinical Practice
-
Continuing evolution of the role of β-blockers in the treatment of hypertension
Thomas D Giles
Review Article: Clinical Practice
-
Inhibition of endothelin-1 with darusentan: a novel antihypertensive approach for the treatment of resistant hypertension
Robert Weiss, Christopher A Graybill, Jennifer Linseman & Marshelle Warren
Drug Evaluation: Clinical Practice
-
Inhibition of endothelin-1 with darusentan: a novel antihypertensive approach for the treatment of resistant hypertension
Robert Weiss, Christopher A Graybill, Jennifer Linseman & Marshelle Warren
Drug Evaluation: Clinical Practice
-
Author guidelines: Volume 5 Issue 4
Appendices: Clinical Practice
-
Author guidelines: Volume 5 Issue 4
Appendices: Clinical Practice
-
Acknowledgment: Volume 5 Issue 3
Appendices: Clinical Practice
-
Acknowledgment: Volume 5 Issue 3
Appendices: Clinical Practice
-
Glycemic control for hospitalized patients with diabetes: strategies for effective management
Lisel M Loney-Hutchinson and Samy I McFarlane
Editorial: Clinical Practice
-
Glycemic control for hospitalized patients with diabetes: strategies for effective management
Lisel M Loney-Hutchinson and Samy I McFarlane
Editorial: Clinical Practice
-
Portal hypertension: the management of esophageal/gastric varices, portal hypertensive gastropathy or hypertensive colopathy
Giampaolo Bresci
Review Article: Clinical Practice
-
Portal hypertension: the management of esophageal/gastric varices, portal hypertensive gastropathy or hypertensive colopathy
Giampaolo Bresci
Review Article: Clinical Practice
Relevant Topics in Clinical